Literature DB >> 11069926

Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis.

M Stefan1, A Koch, A Mancini, A Mohr, K M Weidner, H Niemann, T Tamura.   

Abstract

Hepatocyte growth factor (HGF)/scatter factor is a multifunctional cytokine that induces mitogenesis, motility, and morphogenesis in epithelial, endothelial, and neuronal cells. The receptor for HGF/scatter factor was identified as c-Met tyrosine kinase, and activation of the receptor induces multiple signaling cascades. To gain further insight into c-Met-mediated multiple events at a molecular level, we isolated several signaling molecules including a novel binding partner of c-Met, SH2 domain-containing inositol 5-phosphatase 1 (SHIP-1). Western blot analysis revealed that SHIP-1 is expressed in the epithelial cell line, Madin-Darby canine kidney (MDCK) cells. SHIP-1 binds at phosphotyrosine 1356 at the multifunctional docking site. Because a number of signaling molecules such as Grb2, phosphatidylinositol 3-kinase, and Gab1 bind to the multifunctional docking site, we further performed an in vitro competition study using glutathione S-transferase- or His-tagged signaling molecules with c-Met tyrosine kinase. Our binding study revealed that SHIP-1, Grb2, and Gab1 bound preferentially over phosphatidylinositol 3-kinase. Surprisingly, MDCK cells that overexpress SHIP-1 demonstrated branching tubulogenesis within 2 days after HGF treatment, whereas wild-type MDCK cells showed tubulogenesis only after 6 days following treatment without altering cell scattering or cell growth potency. Furthermore, overexpression of a mutant SHIP-1 lacking catalytic activity impaired HGF-mediated branching tubulogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069926     DOI: 10.1074/jbc.M009333200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways.

Authors:  G Guasch; V Ollendorff; J P Borg; D Birnbaum; M J Pébusque
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.

Authors:  K Nishigaki; D Thompson; C Hanson; T Yugawa; S Ruscetti
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 3.  Role of HGF/MET axis in resistance of lung cancer to contemporary management.

Authors:  Kanwal Pratap Singh Raghav; Ana Maria Gonzalez-Angulo; George R Blumenschein
Journal:  Transl Lung Cancer Res       Date:  2012-09

4.  The autism risk genes MET and PLAUR differentially impact cortical development.

Authors:  Kathie L Eagleson; Daniel B Campbell; Barbara L Thompson; Mica Y Bergman; Pat Levitt
Journal:  Autism Res       Date:  2010-12-03       Impact factor: 5.216

5.  Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.

Authors:  Zi Wang; Yao Nie; Kunxiao Zhang; Henghao Xu; Theresa A Ramelot; Michael A Kennedy; Maili Liu; Jiang Zhu; Yunhuang Yang
Journal:  Arch Biochem Biophys       Date:  2018-08-27       Impact factor: 4.013

6.  A new synaptic player leading to autism risk: Met receptor tyrosine kinase.

Authors:  Matthew C Judson; Kathie L Eagleson; Pat Levitt
Journal:  J Neurodev Disord       Date:  2011-04-21       Impact factor: 4.025

Review 7.  Physiological Signaling and Structure of the HGF Receptor MET.

Authors:  Gianluca Baldanzi; Andrea Graziani
Journal:  Biomedicines       Date:  2014-12-31

8.  Reduced HGF/MET Signaling May Contribute to the Synaptic Pathology in an Alzheimer's Disease Mouse Model.

Authors:  Jing Wei; Xiaokuang Ma; Antoine Nehme; Yuehua Cui; Le Zhang; Shenfeng Qiu
Journal:  Front Aging Neurosci       Date:  2022-07-12       Impact factor: 5.702

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.